Tolterodine: As effective but better tolerated than oxybutynin in Asian patients with symptoms of overactive bladder
Open Access
- 1 May 2002
- journal article
- clinical trial
- Published by Wiley in International Journal of Urology
- Vol. 9 (5) , 247-252
- https://doi.org/10.1046/j.1442-2042.2002.00460.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- How widespread are the symptoms of an overactive bladder and how are they managed? A population‐based prevalence studyBJU International, 2001
- TolterodineDrugs & Aging, 2001
- Twelve-Month Treatment of Overactive BladderDrugs & Aging, 2001
- Tolterodine, an Effective and Well Tolerated Treatment for Urge Incontinence and Other Overactive Bladder SymptomsClinical Drug Investigation, 2000
- Quality‐of‐life aspects of the overactive bladder and the effect of treatment with tolterodineBJU International, 1999
- Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladderBritish Journal of Urology, 1998
- The patient with an overactive bladder—Symptoms and quality-of-life issuesUrology, 1997
- Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: A pooled analysisUrology, 1997
- OxybutyninDrugs & Aging, 1995
- Urodynamic and other effects of tolterodine: A novel antimuscarinic drug for the treatment of detrusor overactivityNeurourology and Urodynamics, 1995